Werewolf Therapeutics, Inc.
HOWL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $66 | $78 | $92 | $111 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $2 | $2 |
| Total Curr. Assets | $68 | $80 | $94 | $113 |
| Property Plant & Equip (Net) | $11 | $11 | $12 | $12 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $11 | $12 | $13 | $14 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $80 | $93 | $107 | $127 |
| Liabilities | – | – | – | – |
| Payables | $1 | $3 | $1 | $3 |
| Short-Term Debt | $6 | $2 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $2 | $4 |
| Total Curr. Liab. | $18 | $15 | $12 | $15 |
| LT Debt | $22 | $25 | $27 | $26 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $3 | $3 | $3 |
| Total NC Liab. | $32 | $36 | $38 | $38 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $10 | $10 | $10 | $11 |
| Total Liabilities | $50 | $51 | $50 | $54 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$467 | -$451 | -$433 | -$415 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $30 | $41 | $57 | $73 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $80 | $93 | $107 | $127 |
| Net Debt | -$38 | -$50 | -$65 | -$85 |